Skip to Content
Learn about Adcetris a treatment of Hodgkin Lymphoma

Fludarabine Pregnancy and Breastfeeding Warnings

Fludarabine is also known as: Fludara, Oforta

Medically reviewed on Oct 22, 2018

Fludarabine Pregnancy Warnings

Fludarabine has been assigned to pregnancy category D by the FDA. Animal data have revealed evidence teratogenicity (increased incidence of various skeletal malformations and external deformities) and embryolethality. There are no data from controlled human pregnancy studies. Fludarabine may cause fetal harm when administered to a pregnant woman. If fludarabine is used during pregnancy, or if the patient becomes pregnant while taking this drug, the patient should be apprised of the potential hazard to the fetus. Women of childbearing potential should be advised to avoid becoming pregnant. Fludarabine is considered contraindicated during pregnancy.

See references

Fludarabine Breastfeeding Warnings

There are no data on the excretion of fludarabine into human milk. Because many drugs are excreted into human milk and because of the potential for serious adverse reactions in nursing infants from this drug, a decision should be made to discontinue nursing or discontinue the drug, taking into account the importance of the drug for the mother.

See references

References for pregnancy information

  1. "Product Information. Fludara (fludarabine)." Berlex, Richmond, CA.

References for breastfeeding information

  1. "Product Information. Fludara (fludarabine)." Berlex, Richmond, CA.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.